Setting the Record Date (Share Register)
In accordance with Article 354 of the Korean Commercial Act and Article 14 of the Articles of Incorporation of Orum Therapeutics Inc., we hereby announce the record date as outlined below to determine shareholders eligible to exercise voting rights at the upcoming extraordinary general meeting.
1. Record Date (Shareholder Determination Date): July 10, 2025 (July 17, 2025)
2. Purpose: To determine the shareholders entitled to vote at the upcoming extraordinary general meeting.
Date: June 25, 2025
Orum Therapeutics Inc.
281-25 Munji-ro, Yuseong-gu, Daejeon, Korea
CEO Sung Joo Lee
Transfer Agent
Korea Securities Depository
CEO Soonho Lee
